Prevalence of FGIDs and Probiotics Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-1
SponsorChulalongkorn University
About this trial
This is a study to evaluate the prevalence of FGIDs in infants using the Thai version of Rome IV diagnostic questionnaire for functional gastrointestinal disorders in infants and evaluate the efficacy of Limosilactobacillus reuteri DSM 17938 to prevent FGIDs in infants.
Eligibility criteria
Qualifiers
Healthy and term (GA 37-41 weeks) infants
Appropriate weight for age
APGAR score more than 8 at 10 minutes of life
Normal physical examination
Disqualifiers
not willing to anticipate in the study
cannot come to follow-up until 1 year of age
Trial design
Treatments tested in this trial
- Biogaia
- Placebo
Treatment groups
512 Participants
are divided into 2 treatment groupsLocations
1Maha Chakri Sirindhorn Clinical Research Center (Chula CRC)10330, BangkokBangkok, Thailand
Sponsors and collaborators
Chulalongkorn University
Lead sponsor
Source ClinicalTrials.gov